These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months. Frasson E; Brigo F; Acler M; Didonè G; Vicentini S; Bertolasi L Arch Dermatol; 2011 Jan; 147(1):122-3. PubMed ID: 21242408 [No Abstract] [Full Text] [Related]
23. Complications and adverse reactions with the use of botulinum toxin. Klein AW Dis Mon; 2002 May; 48(5):336-56. PubMed ID: 12195264 [TBL] [Abstract][Full Text] [Related]
24. Botulinum toxin: examining duration of effect in facial aesthetic applications. Flynn TC Am J Clin Dermatol; 2010; 11(3):183-99. PubMed ID: 20369902 [TBL] [Abstract][Full Text] [Related]
25. Botulinum toxin B: the new option in cosmetic injection. Spencer JM J Drugs Dermatol; 2002 Jul; 1(1):17-22. PubMed ID: 12847750 [TBL] [Abstract][Full Text] [Related]
27. Information from your family doctor. Cosmetic botulinum toxin injection. Am Fam Physician; 2014 Aug; 90(3):Online. PubMed ID: 25077726 [No Abstract] [Full Text] [Related]
28. Cosmetic botulinum toxin injections. Carter SR; Seiff SR Int Ophthalmol Clin; 1997; 37(3):69-79. PubMed ID: 9279643 [No Abstract] [Full Text] [Related]
29. Antibody-induced failure of botulinum toxin a therapy in cosmetic indications. Dressler D; Wohlfahrt K; Meyer-Rogge E; Wiest L; Bigalke H Dermatol Surg; 2010 Dec; 36 Suppl 4():2182-7. PubMed ID: 21134050 [TBL] [Abstract][Full Text] [Related]
30. Practical aspects of cosmetic botulinum toxin. Mannor GE Int Ophthalmol Clin; 2005; 45(3):99-106. PubMed ID: 15970769 [No Abstract] [Full Text] [Related]
31. Evidence for effectiveness of botulinum toxin for hyperhidrosis. Bhidayasiri R; Truong DD J Neural Transm (Vienna); 2008; 115(4):641-5. PubMed ID: 17885725 [TBL] [Abstract][Full Text] [Related]
32. [Facial anatomy and botulinum toxin: the muscular balances]. Trevidic P; Cauchois R; Ingallina F Ann Dermatol Venereol; 2009 May; 136 Suppl 4():S61-6. PubMed ID: 19576487 [TBL] [Abstract][Full Text] [Related]
33. Botulinum toxin type A and B improve quality of life in patients with axillary and palmar hyperhidrosis. Rosell K; Hymnelius K; Swartling C Acta Derm Venereol; 2013 May; 93(3):335-9. PubMed ID: 23053164 [TBL] [Abstract][Full Text] [Related]
34. Pilot study of the safety and efficacy of Myobloc (botulinum toxin type B) for treatment of axillary hyperhidrosis. Baumann L; Slezinger A; Halem M; Vujevich J; Martin LK; Black L; Bryde J Int J Dermatol; 2005 May; 44(5):418-24. PubMed ID: 15869543 [TBL] [Abstract][Full Text] [Related]